Advertisement

Topics

Sosei to Advance Clinical Development in Japan of HTL0018318 in Patients with Dementia with ...

21:06 EST 8 Nov 2017 | BioMedReports - Blog

HTL0018318 is a novel muscarinic M1 receptor agonist in clinical development as a potential treatment for cognitive impairment in Alzheimer’s disease

Read more...

Original Article: Sosei to Advance Clinical Development in Japan of HTL0018318 in Patients with Dementia with ...

NEXT ARTICLE

More From BioPortfolio on "Sosei to Advance Clinical Development in Japan of HTL0018318 in Patients with Dementia with ..."

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...